İ. Selvi, "Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)"," NEUROUROLOGY AND URODYNAMICS , vol.40, no.2, pp.735-736, 2021
Selvi, İ. 2021. Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)". NEUROUROLOGY AND URODYNAMICS , vol.40, no.2 , 735-736.
Selvi, İ., (2021). Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)". NEUROUROLOGY AND URODYNAMICS , vol.40, no.2, 735-736.
Selvi, İsmail. "Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)"," NEUROUROLOGY AND URODYNAMICS , vol.40, no.2, 735-736, 2021
Selvi, İsmail. "Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)"." NEUROUROLOGY AND URODYNAMICS , vol.40, no.2, pp.735-736, 2021
Selvi, İ. (2021) . "Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)"." NEUROUROLOGY AND URODYNAMICS , vol.40, no.2, pp.735-736.
@article{article, author={İsmail SELVİ}, title={Comment on "A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study)"}, journal={NEUROUROLOGY AND URODYNAMICS}, year=2021, pages={735-736} }